NFATc1 — Nuclear Factor of Activated T Cells 1

Migration, Crosslink

📖

NFATc1 — Nuclear Factor of Activated T Cells 1

active

wiki page Created: 2026-04-02T07:19:16 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nfatc1

📖 Wiki Page

gene1384 wordssynced 2026-04-02

NFATc1 — Nuclear Factor of Activated T Cells 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NFATc1 — Nuclear Factor of Activated T Cells 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NFATc1 / NFATC1</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Nuclear factor of activated T-cells, cytoplasmic 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q23</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4776</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95644</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>NFAT1, NFATc1, NF-ATc1</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Properties</td>
</tr>
<tr>
<td class="label">NFATc1α</td>
<td>Full-length, highest molecular weight</td>
</tr>
<tr>
<td class="label">NFATc1β</td>
<td>Truncated N-terminus</td>
</tr>
<tr>
<td class="label">NFATc1γ</td>
<td>Alternative splicing variant</td>
</tr>
<tr>
<td class="label">NFATc1δ</td>
<td>Short isoform</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal transactivation domain</td>
<td>Transcriptional activation</td>
</tr>
<tr>
<td class="label">Rel homology region (RHR)</td>
<td>DNA binding</td>
</tr>
<tr>
<td class="label">NFAT homology region (NHR)</td>
<td>Calcineurin binding, regulation</td>
</tr>
<tr>
<td clas

...

NFATc1 — Nuclear Factor of Activated T Cells 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NFATc1 — Nuclear Factor of Activated T Cells 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NFATc1 / NFATC1</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Nuclear factor of activated T-cells, cytoplasmic 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q23</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4776</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95644</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>NFAT1, NFATc1, NF-ATc1</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Properties</td>
</tr>
<tr>
<td class="label">NFATc1α</td>
<td>Full-length, highest molecular weight</td>
</tr>
<tr>
<td class="label">NFATc1β</td>
<td>Truncated N-terminus</td>
</tr>
<tr>
<td class="label">NFATc1γ</td>
<td>Alternative splicing variant</td>
</tr>
<tr>
<td class="label">NFATc1δ</td>
<td>Short isoform</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal transactivation domain</td>
<td>Transcriptional activation</td>
</tr>
<tr>
<td class="label">Rel homology region (RHR)</td>
<td>DNA binding</td>
</tr>
<tr>
<td class="label">NFAT homology region (NHR)</td>
<td>Calcineurin binding, regulation</td>
</tr>
<tr>
<td class="label">Serine-rich region (SRR)</td>
<td>Phosphorylation sites</td>
</tr>
<tr>
<td class="label">Regulatory domain</td>
<td>Calcium/calcineurin responsiveness</td>
</tr>
<tr>
<td class="label">Process</td>
<td>NFATc1 Role</td>
</tr>
<tr>
<td class="label">Long-term potentiation (LTP)</td>
<td>Regulates BDNF and other plasticity genes</td>
</tr>
<tr>
<td class="label">Long-term depression (LTD)</td>
<td>Controls AMPA receptor endocytosis genes</td>
</tr>
<tr>
<td class="label">Synaptic scaling</td>
<td>Modifies synaptic strength</td>
</tr>
<tr>
<td class="label">Dendritic spine remodeling</td>
<td>Regulates cytoskeletal proteins</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Cyclosporine A</td>
<td>Calcineurin inhibitor</td>
</tr>
<tr>
<td class="label">Tacrolimus (FK506)</td>
<td>Calcineurin inhibitor</td>
</tr>
<tr>
<td class="label">FK506 analogs</td>
<td>Selective NFAT inhibition</td>
</tr>
<tr>
<td class="label">GSK3β inhibitors</td>
<td>Prevent NFAT nuclear export</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Excitatory neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Inhibitory interneurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Category</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Cytokines</td>
<td>IL-1β, TNF-α, IL-6</td>
</tr>
<tr>
<td class="label">Growth factors</td>
<td>BDNF, NGF</td>
</tr>
<tr>
<td class="label">Synaptic proteins</td>
<td>Synapsin, PSD-95</td>
</tr>
<tr>
<td class="label">Transcription factors</td>
<td>c-Fos, Egr-1</td>
</tr>
<tr>
<td class="label">Channel proteins</td>
<td>Cav1.2, Kv channels</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Calcineurin (CaN)</td>
<td>Dephosphorylation</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">CK1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">CREB</td>
<td>Co-activation</td>
</tr>
<tr>
<td class="label">CBP/p300</td>
<td>Co-activator</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">39 edges</a></td>
</tr>
</table>

Overview

Mermaid diagram (expand to render)

NFATc1 (Nuclear Factor of Activated T Cells, Cytoplasmic 1), also known as NFATC1, encodes a member of the NFAT family of calcium-dependent transcription factors. Originally characterized in immune cells where they regulate cytokine gene expression, NFAT proteins are now recognized as crucial regulators of neuronal development, synaptic plasticity, and glial cell function. Dysregulated NFAT signaling contributes to neuroinflammation and neurodegeneration in Alzheimer's disease, Parkinson's disease, and other neurological disorders["@nguyen2023"].

Structure and Function

Isoforms

NFATc1 has multiple isoforms generated by alternative splicing:

Domain Architecture

Activation Mechanism

NFATc1 is a calcium-dependent transcription factor activated through a well-characterized pathway:

Calcium influx: Through voltage-gated calcium channels or NMDA receptors

Calcineurin activation: Calcium/calmodulin binds and activates calcineurin (CaN)

Dephosphorylation: Calcineurin dephosphorylates NFATc1 (removes phosphate groups)

Nuclear translocation: Dephosphorylated NFATc1 enters the nucleus

Gene transcription: NFATc1 binds DNA and regulates target genes

Phosphorylation by kinases (GSK3β, CK1) drives NFATc1 back to the cytoplasm[@aboudaoud2021].

Normal Physiological Functions

Neuronal Functions

Synaptic Plasticity

NFATc1 regulates activity-dependent gene transcription critical for synaptic plasticity:

Neuronal Development

During development, NFATc1 controls[@graef1999]:

Axonal guidance
Dendritic arborization
Synapse formation
Neuronal survival

Axonal Regeneration

NFATc1 activity influences:

Growth cone dynamics
Axonal sprouting
regeneration-associated genes

Glial Functions

Microglial Activation

NFATc1 is a key transcription factor in microglia:

Regulates cytokine gene expression (IL-1β, TNF-α, IL-6)
Controls immune response genes
Modulates phagocytic activity[benne2021]

Astrocyte Function

In astrocytes, NFATc1:

Regulates inflammatory gene expression
Controls water channel expression (AQP4)
Modulates glutamate uptake

Role in Neurodegenerative Diseases

Alzheimer's Disease

NFATc1 dysregulation is implicated in multiple aspects of AD pathogenesis[@reddy2022]:

Neuroinflammation:

NFATc1 in microglia drives pro-inflammatory cytokine production
Aβ oligomers trigger NFATc1 activation
Chronic NFATc1 activation contributes to chronic inflammation

Synaptic Dysfunction:

NFATc1 regulates synaptic plasticity genes altered in AD
Calcineurin/NFAT signaling is impaired
May contribute to memory deficits

Tau Pathology:

NFATc1 activity affects tau phosphorylation kinases
Tau pathology alters NFATc1 nuclear localization
Bidirectional relationship[ sompol2019]

Therapeutic Potential:

NFAT inhibitors may reduce neuroinflammation
[Microglia](/cell-types/microglia)specific targeting may avoid immunosuppression
Calcineurin inhibitors being investigated

Parkinson's Disease

NFATc1 plays complex roles in PD[@yoshida2018]:

Dopaminergic Neurons:

NFATc1 activation in substantia nigra
May regulate inflammatory responses
Contributes to chronic neuroinflammation

Microglial Activation:

NFATc1 drives microglial activation
Cytokine production affects neurons
Creates vicious cycle of neurodegeneration

Therapeutic Implications:

NFAT pathway inhibition may protect neurons
Anti-inflammatory strategies targeting NFAT

Amyotrophic Lateral Sclerosis (ALS)

NFATc1 is activated in ALS and contributes to disease progression[wulans2019]:

Motor neuron expression of NFATc1
Astrocyte and microglial activation
Inflammatory gene expression
Potential therapeutic target

Stroke and Ischemia

Post-ischemic inflammation involves NFATc1[sato2019]:

NFATc1 activation in response to ischemia
Pro-inflammatory gene expression
Contributes to secondary damage
NFAT inhibition may be protective

Multiple Sclerosis

NFAT in demyelination and remyelination
Immune cell regulation
Oligodendrocyte function

Clinical Significance

Autoimmune Disorders

Systemic lupus erythematosus: NFATc1 dysregulation
Rheumatoid arthritis: T-cell activation
Transplant rejection: Calcineurin inhibitors used clinically

Cancer

NFATc1 can act as oncogene or tumor suppressor
Context-dependent effects
Some lymphomas show NFATc1 overexpression

Therapeutic Targeting

Calcineurin-NFAT Pathway Inhibitors

Challenges

Systemic immunosuppression: Broad calcineurin inhibition
Narrow therapeutic window: Toxicity concerns
CNS penetration: Drug delivery to brain

Future Directions

Microglia-selective inhibitors: Targeted anti-inflammatory
NFATc1-specific targeting: Avoiding other NFATs
Combination therapies: With other disease-modifying approaches[yang2021]

Expression Pattern

Brain Regions

NFATc1 is expressed throughout the brain:

Cell Type Specificity

Molecular Mechanisms

Transcriptional Targets

NFATc1 regulates numerous target genes:

Signaling Cross-talk

cAMP/PKA: Modulates NFAT activity
MAPK/ERK: Phosphorylates NFATc1
PI3K/Akt: NFAT nuclear export regulation
GSK3β: Controls NFAT nuclear localization

Key Interactions

Animal Models

Knockout Mice

Nfatc1-/-: Embryonic lethal (defects in heart, immune system)
Conditional knockouts: Brain-specific deletion viable
Phenotype: Altered immune function, synaptic plasticity defects

Transgenic Models

NFATc1 overexpression: In neurons, astrocytes, microglia
Dominant-negative: Block NFAT signaling
Reporter lines: Monitor NFAT activity

Disease Models

AD models: APP/PS1, 5xFAD crossed with NFAT mutants
PD models: MPTP, α-synuclein transgenic
Stroke models: Transient MCAO

Research Methods

Molecular Biology

Reporter constructs (NFAT-luciferase)
ChIP-seq for NFAT binding sites
RNA-seq after NFAT modulation

Electrophysiology

Whole-cell patch-clamp
LTP/LTD recordings
Calcium imaging

Imaging

NFATc1 nuclear translocation
Live-cell imaging of NFAT dynamics
Immunohistochemistry for NFAT localization

References

[Nguyen & Dzialo, NFAT in neuroinflammation (2023)](https://pubmed.ncbi.nlm.nih.gov/36739754/)

[Reddy et al., Calcineurin-NFAT in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35441267/)

[Abou-Daoud et al., NFAT in the brain (2021)](https://pubmed.ncbi.nlm.nih.gov/34013554/)

[Huang et al., NFAT in synaptic plasticity (2018)](https://pubmed.ncbi.nlm.nih.gov/29483655/)

[Graef et al., NFAT in neural development (1999)](https://pubmed.ncbi.nlm.nih.gov/10518220/)

[Benne et al., NFAT in microglia (2021)](https://pubmed.ncbi.nlm.nih.gov/34041731/)

[Choi et al., Targeting NFAT in inflammation (2016)](https://pubmed.ncbi.nlm.nih.gov/27292652/)

[Sompol et al., NFAT and tau (2019)](https://pubmed.ncbi.nlm.nih.gov/31082967/)

[Yoshida et al., NFATc1 in PD (2018)](https://pubmed.ncbi.nlm.nih.gov/29539485/)

[Wulans et al., NFAT in ALS (2019)](https://pubmed.ncbi.nlm.nih.gov/31326578/)

[Cruz et al., NFAT in neurons and glia (2017)](https://pubmed.ncbi.nlm.nih.gov/28646118/)

[Kim et al., NFAT in synaptic depression (2020)](https://pubmed.ncbi.nlm.nih.gov/32956565/)

[Park et al., NFAT and dendritic arborization (2017)](https://pubmed.ncbi.nlm.nih.gov/28751454/)

[Liu et al., NFATc1 in neuroinflammation (2018)](https://pubmed.ncbi.nlm.nih.gov/29747687/)

[Schneider et al., NFAT in astrocytes (2019)](https://pubmed.ncbi.nlm.nih.gov/31468948/)

[Lechner et al., Calcineurin inhibitors in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30181274/)

[Martinez et al., NFAT and autophagy (2017)](https://pubmed.ncbi.nlm.nih.gov/28245628/)

[Vasquez et al., NFAT transcriptional responses (2018)](https://pubmed.ncbi.nlm.nih.gov/29285601/)

[Yang et al., Therapeutic targeting of NFAT (2021)](https://pubmed.ncbi.nlm.nih.gov/34024624/)

[Sato et al., NFAT in stroke (2019)](https://pubmed.ncbi.nlm.nih.gov/31272204/)

Last updated: 2026-03-25

Pathway Diagram

The following diagram shows the key molecular relationships involving NFATc1 — Nuclear Factor of Activated T Cells 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NFATC1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nfatc1
kg_node_id	NFATC1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2bf4bab75945
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nfatc1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

25

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NFATc1 — Nuclear Factor of Activated T Cells 1

NFATc1 — Nuclear Factor of Activated T Cells 1

NFATc1 — Nuclear Factor of Activated T Cells 1

Overview

Structure and Function

Isoforms

Domain Architecture

Activation Mechanism

Normal Physiological Functions

Neuronal Functions

Synaptic Plasticity

Neuronal Development

Axonal Regeneration

Glial Functions

Microglial Activation

Astrocyte Function

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Stroke and Ischemia

Multiple Sclerosis

Clinical Significance

Autoimmune Disorders

Cancer

Therapeutic Targeting

Calcineurin-NFAT Pathway Inhibitors

Challenges

Future Directions

Expression Pattern

Brain Regions

Cell Type Specificity

Molecular Mechanisms

Transcriptional Targets

Signaling Cross-talk

Key Interactions

Animal Models

Knockout Mice

Transgenic Models

Disease Models

Research Methods

Molecular Biology

Electrophysiology

Imaging

See Also

References

Pathway Diagram

💬 Discussion